International ResearchKit App for Women with Menstrual Pain: Development, Access, and Engagement.
ResearchKit
acupressure
behavior change techniques (BCTs)
dysmenorrhea
mHealth
mobile applications
pain
recruitment
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
11 02 2020
11 02 2020
Historique:
received:
01
06
2019
accepted:
12
11
2019
revised:
21
10
2019
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
1
4
2021
Statut:
epublish
Résumé
Primary dysmenorrhea is a common condition in women of reproductive age. A previous app-based study undertaken by our group demonstrated that a smartphone app supporting self-acupressure introduced by a health care professional can reduce menstrual pain. This study aims to evaluate whether a specific smartphone app is effective in reducing menstrual pain in 18- to 34-year-old women with primary dysmenorrhea in a self-care setting. One group of women has access to the full-featured study app and will be compared with 2 control groups who have access to fewer app features. Here, we report the trial design, app development, user access, and engagement. On the basis of the practical implications of the previous app-based study, we revised and reengineered the study app and included the ResearchKit (Apple Inc) framework. Behavior change techniques (BCTs) were implemented in the app and validated by expert ratings. User access was estimated by assessing recruitment progress over time. User evolution and baseline survey respondent rate were assessed to evaluate user engagement. The development of the study app for a 3-armed randomized controlled trial required a multidisciplinary team. The app is accessible for the target population free of charge via the Apple App Store. In Germany, within 9 months, the app was downloaded 1458 times and 328 study participants were recruited using it without external advertising. A total of 98.27% (5157/5248) of the app-based baseline questions were answered. The correct classification of BCTs used in the app required psychological expertise. Conducting an innovative app study requires multidisciplinary effort. Easy access and engagement with such an app can be achieved by recruitment via the App Store. Future research is needed to investigate the determinants of user engagement, optimal BCT application, and potential clinical and self-care scenarios for app use. ClinicalTrials.gov NCT03432611; https://clinicaltrials.gov/ct2/show/NCT03432611 (Archived by WebCite at http://www.webcitation.org/75LLAcnCQ).
Sections du résumé
BACKGROUND
Primary dysmenorrhea is a common condition in women of reproductive age. A previous app-based study undertaken by our group demonstrated that a smartphone app supporting self-acupressure introduced by a health care professional can reduce menstrual pain.
OBJECTIVE
This study aims to evaluate whether a specific smartphone app is effective in reducing menstrual pain in 18- to 34-year-old women with primary dysmenorrhea in a self-care setting. One group of women has access to the full-featured study app and will be compared with 2 control groups who have access to fewer app features. Here, we report the trial design, app development, user access, and engagement.
METHODS
On the basis of the practical implications of the previous app-based study, we revised and reengineered the study app and included the ResearchKit (Apple Inc) framework. Behavior change techniques (BCTs) were implemented in the app and validated by expert ratings. User access was estimated by assessing recruitment progress over time. User evolution and baseline survey respondent rate were assessed to evaluate user engagement.
RESULTS
The development of the study app for a 3-armed randomized controlled trial required a multidisciplinary team. The app is accessible for the target population free of charge via the Apple App Store. In Germany, within 9 months, the app was downloaded 1458 times and 328 study participants were recruited using it without external advertising. A total of 98.27% (5157/5248) of the app-based baseline questions were answered. The correct classification of BCTs used in the app required psychological expertise.
CONCLUSIONS
Conducting an innovative app study requires multidisciplinary effort. Easy access and engagement with such an app can be achieved by recruitment via the App Store. Future research is needed to investigate the determinants of user engagement, optimal BCT application, and potential clinical and self-care scenarios for app use.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03432611; https://clinicaltrials.gov/ct2/show/NCT03432611 (Archived by WebCite at http://www.webcitation.org/75LLAcnCQ).
Identifiants
pubmed: 32058976
pii: v8i2e14661
doi: 10.2196/14661
pmc: PMC7055820
doi:
Banques de données
ClinicalTrials.gov
['NCT03432611']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14661Informations de copyright
©Jiani Wang, Alizé A Rogge, Mike Armour, Caroline A Smith, Christopher R D’Adamo, Claudia R Pischke, Hung-Rong Yen, Mei-Yao Wu, Ari Ojeda Ocampo Moré, Claudia M Witt, Daniel Pach. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 11.02.2020.
Références
Br J Pain. 2016 Aug;10(3):135-40
pubmed: 27583140
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
J Affect Disord. 2018 Feb;227:432-442
pubmed: 29154165
JMIR Diabetes. 2017 Aug 24;2(2):e21
pubmed: 30291059
BMC Complement Altern Med. 2012 Sep 06;12:148
pubmed: 22953730
J Med Internet Res. 2015 Jan 02;17(1):e1
pubmed: 25565416
Acad Med. 2017 Feb;92(2):157-160
pubmed: 27119325
J Womens Health (Larchmt). 2019 Aug;28(8):1161-1171
pubmed: 31170024
Forsch Komplementmed. 2009 Oct;16(5):292-4
pubmed: 19887807
J Med Internet Res. 2015 Jul 22;17(7):e183
pubmed: 26202991
JMIR Mhealth Uhealth. 2015 Jun 29;3(2):e73
pubmed: 26123578
Clin Schizophr Relat Psychoses. 2017 Aug 4;:
pubmed: 28777029
PLoS One. 2017 May 3;12(5):e0176921
pubmed: 28467473
Am Fam Physician. 1999 Aug;60(2):489-96
pubmed: 10465224
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
JMIR Rehabil Assist Technol. 2017 Dec 04;4(2):e11
pubmed: 29203460
JMIR Mhealth Uhealth. 2017 Feb 28;5(2):e23
pubmed: 28246069
JMIR Mhealth Uhealth. 2017 Jul 25;5(7):e108
pubmed: 28743681
JAMA Intern Med. 2017 Jun 1;177(6):765-773
pubmed: 28384682
Sci Data. 2016 Mar 03;3:160011
pubmed: 26938265
BMJ Open. 2016 Jan 05;6(1):e008166
pubmed: 26733563
JMIR Mhealth Uhealth. 2018 Dec 06;6(12):e11271
pubmed: 30522990
Healthcare (Basel). 2016 Jun 08;4(2):
pubmed: 27417619
Implement Sci. 2011 Feb 07;6:10
pubmed: 21299860
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Semin Reprod Med. 2018 Jan;36(1):59-65
pubmed: 30189452
Am J Obstet Gynecol. 2018 Feb;218(2):227.e1-227.e9
pubmed: 29155036
BMJ. 2006 May 13;332(7550):1134-8
pubmed: 16690671
Trials. 2013 Apr 11;14:99
pubmed: 24499425
JMIR Mhealth Uhealth. 2018 Oct 22;6(10):e11231
pubmed: 30348633
BMJ Open. 2019 Jun 27;9(6):e026186
pubmed: 31248919
BMJ Innov. 2016 Jan;2(1):14-21
pubmed: 27019745
J Clin Epidemiol. 2017 Aug;88:113-121
pubmed: 28603007
Sci Data. 2018 May 22;5:180096
pubmed: 29786695
J Gen Intern Med. 2014 Dec;29(12):1692-701
pubmed: 24893581
J Clin Epidemiol. 2017 Apr;84:95-104
pubmed: 28188898
Health Technol Assess. 2015 Nov;19(99):1-188
pubmed: 26616119
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Anesth Analg. 2016 Nov;123(5):1316-1324
pubmed: 27749351
Arch Phys Med Rehabil. 2017 Jan;98(1):80-87
pubmed: 27693421
PLoS One. 2019 Jul 24;14(7):e0220103
pubmed: 31339951
Am J Obstet Gynecol. 2008 Feb;198(2):166.e1-8
pubmed: 18226614
J Telemed Telecare. 2018 Jan;24(1):22-30
pubmed: 27760883
Altern Ther Health Med. 2016 Jul;22(4):60-3
pubmed: 27548494
Rheumatol Int. 2018 Nov;38(11):1949-1957
pubmed: 29713795
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
J Med Internet Res. 2017 Oct 12;19(10):e348
pubmed: 29025693
Nat Biotechnol. 2017 Apr;35(4):354-362
pubmed: 28288104